NFKB1 and liver dysplastic nodule: High glucose, advanced glycosylation end products, angiotensin II and other pathogenic factors for DN can all activate NF-κB pathway in mesangial cells and renal tubular epithelial cells, and then regulate the transcription and synthesis of MCP-1 and RANTES [10], [11].